Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

NCT02062073 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Head Lice

Interventions

DRUG: Abametapir Lotion 0.74% w/w
OTHER: 0.1% sodium lauryl sulfate
OTHER: saline 0.9%
OTHER: Vehicle Lotion

Sponsor

Dr. Reddy's Laboratories Limited

Collaborators

[object Object]
[object Object]